Development of [At-211]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+malignancies

Laszlo, GS; Orozco, JJ; Kehret, AR; Lunn, MC; Huo, J; Hamlin, DK; Wilbur, DS; Dexter, SL; Comstock, ML; O'Steen, S; Sandmaier, BM; Green, DJ; Walter, RB

Walter, RB (通讯作者)，Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA 98109 USA.;Walter, RB (通讯作者)，Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA.;Walter, RB (通讯作者)，Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA.;Walter, RB (通讯作者)，Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.

LEUKEMIA, 2022; 36 (6): 1485

Abstract

Radioimmunotherapy (RIT) has long been pursued to improve outcomes in acute leukemia and higher-risk myelodysplastic syndrome (MDS). Of increasing int......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索